Hans-Veit Coester
Overview
Explore the profile of Hans-Veit Coester including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Herbrand T, Coester H, Sansone R, Fischer A, Heiss C, Heise T, et al.
Angiology
. 2020 Dec;
72(5):434-441.
PMID: 33380161
The assessment of flow-mediated dilation (FMD) is widely used to quantify endothelial function. Historically, FMD was determined at 60 seconds post-cuff deflation. We investigated whether FMD would be more accurate...
2.
Zijlstra E, Coester H, Heise T, Plum-Morschel L, Rasmussen O, Rikte T, et al.
Diabetes Obes Metab
. 2018 Jan;
20(5):1140-1147.
PMID: 29369493
Aims: To evaluate the injection success and user perception of a shield-triggered pen-injector mechanism. Methods: The trial (ClinicalTrials.gov NCT02627287) was an exploratory, two-centre, one-visit, open-label, randomized controlled trial conducted in...
3.
Famulla S, Hovelmann U, Fischer A, Coester H, Hermanski L, Kaltheuner M, et al.
Diabetes Care
. 2016 Jul;
39(9):1486-92.
PMID: 27411698
Objective: Lipohypertrophy (LHT) is common in insulin-treated patients but its exact impact on insulin absorption and action is unclear. Research Design And Methods: In this crossover study, 13 patients with...
4.
Meier J, Rosenstock J, Hincelin-Mery A, Roy-Duval C, Delfolie A, Coester H, et al.
Diabetes Care
. 2015 Apr;
38(7):1263-73.
PMID: 25887358
Objective: This mechanistic trial compared the pharmacodynamics and safety of lixisenatide and liraglutide in combination with optimized insulin glargine with/without metformin in type 2 diabetes (T2D). Research Design And Methods:...
5.
Nosek L, Coester H, Roepstorff C, Thomsen H, Kristensen N, Haahr H, et al.
Clin Drug Investig
. 2014 Aug;
34(9):673-9.
PMID: 25124362
Background And Objectives: Patients with diabetes mellitus inject insulin in different regions of the body. This study investigated the pharmacokinetic and pharmacodynamic properties of insulin degludec (IDeg), a new-generation once-daily...